Previous Article | Next Article ![]()
Journal of Bacteriology, June 2000, p. 3482-3489, Vol. 182, No. 12
Department of Microbiology and Immunology,
Louisiana State University Health Sciences Center, Shreveport,
Louisiana 711301; Department of
Developmental Biology, Stanford University School of Medicine,
Stanford, California 943052; and
National Animal Disease Center, Agricultural Research
Service, U.S. Department of Agriculture, Ames, Iowa
500103
Received 4 February 2000/Accepted 21 March 2000
The CcrM DNA methyltransferase of the
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Brucella abortus CcrM DNA Methyltransferase Is
Essential for Viability, and Its Overexpression Attenuates
Intracellular Replication in Murine Macrophages


-proteobacteria catalyzes
the methylation of the adenine in the sequence GAnTC. Like Dam in the
enterobacteria, CcrM plays a regulatory role in Caulobacter crescentus and Rhizobium meliloti. CcrM is essential
for viability in both of these organisms, and we show here that it is
also essential in Brucella abortus. Further, increased copy
number of the ccrM gene results in striking changes in
B. abortus morphology, DNA replication, and growth in
murine macrophages. We generated strains that carry
ccrM either on a low-copy-number plasmid (strain
GR131) or on a moderate-copy-number plasmid (strain GR132).
Strain GR131 has wild-type morphology and chromosome number, as
assessed by flow cytometry. In contrast, strain GR132 has abnormal
branched morphology, suggesting aberrant cell division, and increased
chromosome number. Although these strains exhibit different
morphologies and DNA content, the replication of both strains in
macrophages is attenuated. These data imply that the reduction in
survival in host cells is not due solely to a cell division defect but is due to additional functions of CcrM. Because CcrM is essential in B. abortus and increased ccrM
copy number attenuates survival in host cells, we propose that CcrM is
an appropriate target for new antibiotics.
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, P.O. Box 33932, Louisiana State University Health Science Center, 1501 Kings Highway, Shreveport, LA 71130-3932. Phone: (318) 675-5771. Fax: (318) 675-5764. E-mail:
rroop{at}lsumc.edu.
Present address: Lilly Research Laboratories, Eli Lilly & Company,
Indianapolis, IN 46285.
Present address: Incyte Pharmaceuticals, Palo Alto, CA 94304.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |